Search

everythinglearnresearchcommunity

for

Search:↓

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

Ribonucleotide excision repair is crucial to prevent skin cancer.

Ribonucleotide excision repair is crucial to prevent skin cancer.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

A hepatitis B patient lost hair in patches after starting and stopping a treatment with pegylated interferon alpha2a.

The combination therapy of PEG-IFN α-2a and Ribavirin can cause widespread hair loss and skin reactions.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

Older age, pre-existing skin conditions, cirrhosis, and pegylated interferon use increase the risk of skin issues during hepatitis C treatment.

A man lost all his hair permanently after hepatitis C treatment, a side effect not seen before.

A man lost all his hair as a rare side effect after hepatitis C treatment.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

JAK inhibitors show promise for treating hair loss in alopecia areata but need more clinical trials to confirm safety and effectiveness.

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

Azathioprine can help with relapses and disability in NMOSD but has more side effects and needs more research.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

A woman with rheumatoid arthritis lost all her hair during adalimumab treatment, and stopping the drug didn't help.

IL-1β inhibits human hair follicle growth.

COVID-19 can cause various skin issues in children, mostly not severe, with chilblain-like lesions being common, especially in adolescents.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Topical minoxidil showed promise for early male pattern baldness.

Some treatments like pentoxifylline with topical corticosteroids might work for alopecia areata, but more research is needed to find the best one.

Discoid Lupus Erythematosus causes scalp plaques that can lead to hair loss, and antimalarial drugs are effective treatments.

Adding colchicine stopped the girl's recurring heart issues caused by lupus.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.